Gene therapy for the treatment of X-linked retinitis pigmentosa

Cristina Martinez-Fernandez De La Camara, Anika Nanda, Anna Paola Salvetti, M. Dominik Fischer, Robert E. MacLaren

Open source

DOI
10.1080/21678707.2018.1444476
Published
2018-02-27
Container
Expert Opinion on Orphan Drugs
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/21678707.2018.1444476,
  title = {Gene therapy for the treatment of X-linked retinitis pigmentosa},
  author = {Cristina Martinez-Fernandez De La Camara and Anika Nanda and Anna Paola Salvetti and M. Dominik Fischer and Robert E. MacLaren},
  year = {2018},
  journal = {Expert Opinion on Orphan Drugs},
  doi = {10.1080/21678707.2018.1444476},
  url = {https://doi.org/10.1080/21678707.2018.1444476}
}

RIS

TY  - JOUR
TI  - Gene therapy for the treatment of X-linked retinitis pigmentosa
AU  - Cristina Martinez-Fernandez De La Camara
AU  - Anika Nanda
AU  - Anna Paola Salvetti
AU  - M. Dominik Fischer
AU  - Robert E. MacLaren
PY  - 2018
JO  - Expert Opinion on Orphan Drugs
DO  - 10.1080/21678707.2018.1444476
UR  - https://doi.org/10.1080/21678707.2018.1444476
ER  - 

APA

Camara, C. M. D. L., Nanda, A., Salvetti, A. P., Fischer, M. D., & MacLaren, R. E. (2018). Gene therapy for the treatment of X-linked retinitis pigmentosa. Expert Opinion on Orphan Drugs. https://doi.org/10.1080/21678707.2018.1444476

Source records